This article discusses some of the biochemical effects of neuropsychiatric drugs for bipolar disorder, focusing in on inositol depletion and GSK3 inhibition interrelatedness as an explanation for valproic acid and lithium efficacy.
Browsing: Future Neurology
This article reviews the targeting of CGRP, a biomarker of migraine, as a treatment for the disorder and efforts to develop mechanism-based therapies.
A new model is proposed that the Basal Ganglia implement the level of transition control in an extended control hierarchy, helping to explain major neurological symptoms.
This review evaluates the availability of health apps for stroke and their potential for widening the evidence base for a range of prevention and intervention protocols in stroke and other medical conditions.
This article reviews the failure of Phase III clinical trials of neuroprotective therapeutics, with particular focus on neurosteroid progesterone, one of the most promising agents.
This review will discuss the role of the complement system in brain degenerative pathology.
This study evaluates sensory responsiveness in juvenile myoclonic epilepsy patients utilizing a range of different biomarkers.
Several factors in combination are necessary to trigger autoimmune complications associated with streptococcus infections. This review looks at the evidence supporting each factor.
Amid the strong clinical need for differential diagnostic biomarkers for parkinsonian disorders, this article examines the proteolytic signatures of patients with multiple system atrophy and non-neurodegenerative controls.
This review explores the current status of diagnosis, management and treatment of CNS germ cell tumors as well future directions for therapies.